FDA approves label expansion for Pfizer’s Prevnar 13
The US Food and Drug Administration (FDA) has approved an expanded age indication for Pfizer’s Prevnar 13 (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]).
Click on this link for more information.
